Orphan Drug Reimbursement In Europe- Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?
Oct 1, 2017, 00:00
10.1016/j.jval.2017.08.373
https://www.valueinhealthjournal.com/article/S1098-3015(17)30707-6/fulltext
Title :
Orphan Drug Reimbursement In Europe- Do Less Stringent Regulatory Requirements Translate Into Less Favourable Reimbursement?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(17)30707-6&doi=10.1016/j.jval.2017.08.373
First page :
A464
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
348